0469-6501Level 3
LEXISCAN (regadenoson)
**Product type:** Human Prescription Drug
**Active ingredient:** REGADENOSON
**Strength:** .08 mg/mL
**Dosage form:** Injection, Solution
**Route:** Intravenous
**Labeler:** Astellas Pharma US, Inc.
**Marketing category:** NDA (NDA022161)
**Pharmacologic class:** Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA]
GET
/api/v1/systems/ndc_fda/nodes/0469-6501Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.